5 Worst Stock Picks of Cathie Wood in 2022

2. Senti Biosciences, Inc. (NASDAQ:SNTI)

Negative Percentage Change From 52 Week High: 82.20%

Number of Hedge Fund Holders In Q3 2022: 3

Senti Biosciences, Inc. (NASDAQ:SNTI) is another San Francisco based biotechnology firm. It develops genetic and cellular treatments for cancers such as leukemia and carcinoma.

Senti Biosciences, Inc. (NASDAQ:SNTI) is aiming to submit Investigational New Drug (IND) applications to the FDA for its cancer treatments during the second half of this year. As part of their third quarter of 2022 investments, three of the 920 hedge funds polled by Insider Monkey had bought the firm’s shares.

Follow Senti Biosciences Inc.